Association of SOGPI in mediating the effect of Phosphatidylcholine on polycystic Ovary Syndrome DOI Creative Commons
Qian Guo, Wei Wang, Jie Chen

и другие.

Gynecological Endocrinology, Год журнала: 2024, Номер 40(1)

Опубликована: Окт. 26, 2024

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in women of reproductive age, marked by hormonal imbalances and disruptions glucose lipid metabolism. Emerging research has indicated correlation between lipids PCOS, yet the specific profiles or associated genes identified various studies vary, observational data alone cannot establish causation. Therefore, our study seeks to causal association lipidome PCOS.

Язык: Английский

Microbes Saving Lives and Reducing Suffering DOI Creative Commons
Kenneth N. Timmis, Zeynep Ceren Karahan, Juan L. Ramos

и другие.

Microbial Biotechnology, Год журнала: 2025, Номер 18(1)

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

3

Changes in Hormonal Profile and Body Mass Index in Women with Polycystic Ovary Syndrome After Probiotic Intake: A 12-Week Placebo-Controlled and Randomized Clinical Study DOI Open Access
Iwona Szydłowska, Jolanta Nawrocka-Rutkowska, Amalia Gorzko

и другие.

Nutrients, Год журнала: 2025, Номер 17(3), С. 405 - 405

Опубликована: Янв. 23, 2025

Introduction: The beneficial effect of probiotics on the improvement carbohydrate and lipid metabolism, as well body mass index (BMI), has been demonstrated in various patient groups. We aimed to investigate a multi-strain probiotic hormonal balance women with PCOS. Ethical approval was obtained from Bioethical Committee. Methods: study designed 12-week, randomized, double-blind, placebo-controlled clinical study. SanProbi® Barrier capsules, which contain unique composition nine bacteria strains (Lactobacillus Biffidobacterium), were used mean age participants 28.42 ± 5.62 years. A total 50 PCOS, diagnosed based Rotterdam ESHRE criteria, included Among them, 25 randomized placebo group, group. Results: comparison changes individual hormone levels between groups confirmed statistically significant differences for TSH, androstenedione, SHBG, BMI. In case LH, statistical significance difference delta change group use one-tailed test. Conclusions: Probiotic supplementation may serve an alternative supporting treatment, especially phenotype high FAI index. therapy is also effective reducing BMI overweight PCOS

Язык: Английский

Процитировано

1

Introduction to Polycystic Ovary Syndrome (PCOS) and Nutritional Challenges DOI
Bancha Yingngam,

Chakkrapong Chaiburi,

Abhiruj Navabhatra

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

The association between triglyceride glucose-body Mass Index and in vitro fertilization outcomes in women with polycystic ovary syndrome: a cohort study DOI Creative Commons
Xin Li, Ting Luan, Yi Wei

и другие.

Journal of Ovarian Research, Год журнала: 2024, Номер 17(1)

Опубликована: Апрель 26, 2024

Abstract Background Polycystic Ovary Syndrome (PCOS) is a common reproductive disorder that frequently affects fertility. The TyG-BMI (Triglyceride glucose-body mass) index newly explored parameter may be linked to results in individuals with PCOS. Nevertheless, its connection outcomes In Vitro Fertilization (IVF) procedures remains uncertain. Methods This study included total of 966 females who underwent IVF treatments for At the baseline, participants were categorized into four groups according quartiles measured prior oocyte retrieval. Subsequently, compared differences clinical and laboratory among these groups. Results Patients higher exhibited decreased number retrieved oocytes, 2PN embryos, available/high-quality embryos ( P < 0.05 Q1-Q4). Additionally, multivariable regression analysis revealed top quartile had lower count accessible (β = -0.224, 0.257) high-quality -0.352, 0.028) comparison those lowest quartile. there no notable variances detected rates pregnancy or live births quartiles. Furthermore, linear correlation was noted between quantity -non-linear 0.6, -overall 0.001), along -nonlinear 0.026, 0.006). contrast, found available embryo rate 0.60, 0.8). Conclusions this research emphasize diagnosed interplay insulin resistance disorders lipid metabolism indeed play pivotal role influencing assisted patients Considering findings, proves valuable indicator exploring potential association.

Язык: Английский

Процитировано

2

The modern pathogenetic challenges of polycystic ovary syndrome DOI Creative Commons
Л. В. Пахаренко, N.Ya. Zhylka, О.S. Shcherbinska

и другие.

Reproductive health of woman, Год журнала: 2024, Номер 2, С. 75 - 80

Опубликована: Март 9, 2024

Polycystic ovary syndrome (PCOS) is one of the neuroendocrine syndromes in women reproductive age. In pathogenesis its development a great importance paid to hormonal disbalance, metabolic changes, overweight and obesity, diabetes mellitus, insulin resistance, genetic factors, etc. Very often, PCOS accompanied by infertility, cardiovascular risks, mellitus.The article devoted review modern scientific literature about last researches mechanisms disorders which are connected with also, psychological disturbance stress. The describes specific conditions patients. On basis analyzed publications connection between disorders, overweight, obesity lipidogram parameters presented.Also, gut vaginal microbiota described this paper. studies demonstrate significant changes human microbiome course polycystic syndrome. presents concepts difference composition vagina syndrome.The pathogenetic role processes pathogenesis, namely, regulation immune response inflammation pathology, described. It has been shown that there differences microflora intestines, manifested decreased concentration Lactobacillus presence variety other microorganisms compared healthy women.Thus, main links closely each other. That why multimodal approaches for study management patients extremely important.

Язык: Английский

Процитировано

2

Butyrate as a Potential Modulator in Gynecological Disease Progression DOI Open Access

Nayeon Kim,

Changwon Yang

Nutrients, Год журнала: 2024, Номер 16(23), С. 4196 - 4196

Опубликована: Дек. 4, 2024

This review investigates the therapeutic potential of butyrate, a short-chain fatty acid (SCFA) produced by gut microbiota, in prevention and treatment various gynecological diseases, including polycystic ovary syndrome (PCOS), endometriosis, gynecologic cancers like cervical ovarian cancer. These conditions often pose challenges, with conventional therapies offering limited temporary relief, significant side effects, risk recurrence. Emerging evidence highlights butyrate's unique biological activities, particularly its role as histone deacetylase (HDAC) inhibitor, which allows it to modulate gene expression, immune responses, inflammation. In PCOS, butyrate aids restoring hormonal balance, enhancing insulin sensitivity, reducing chronic For appears suppress dysregulation minimize lesion proliferation. Additionally, cancers, demonstrates anticancer effects through mechanisms such cell cycle arrest, apoptosis induction, suppression tumor progression. Dietary interventions, high-fiber Mediterranean diets, that increase production are proposed complementary approaches, supporting natural microbiota modulation enhance outcomes. However, short half-life limits clinical application, spurring interest analogs probiotics maintain stable levels extend benefits. consolidates current findings on multifaceted impact across health, highlighting for microbiota-centered advancing strategies improving women's reproductive health.

Язык: Английский

Процитировано

1

Should Pregnant Women Consume Probiotics to Combat Endocrine-Disrupting Chemical-Induced Health Risks to Their Unborn Offspring? DOI Creative Commons
Cheryl S. Rosenfeld

Biomedicines, Год журнала: 2024, Номер 12(8), С. 1628 - 1628

Опубликована: Июль 23, 2024

Endocrine-disrupting chemicals (EDCs) have become so pervasive in our environment and daily lives that it is impossible to avoid contact with such compounds, including pregnant women seeking minimize exposures themselves their unborn children. Developmental exposure of humans rodent models bisphenol A (BPA) other EDCs linked increased anxiogenic behaviors, learning memory deficits, decreased socio-sexual behaviors. Prenatal BPA leads longstanding harmful effects on gut microbiota reductions beneficial bacteria, i.e., dysbiosis, microbial changes are host fecal metabolites, those involved carbohydrate metabolism synthesis, neurobehavioral alterations adulthood, particular, social cognitive deficits. Gut dysbiosis increasingly being recognized as a key driver myriad diseases, ranging from metabolic, cardiovascular, reproductive, disorders via the gut-microbiome-brain axis. Thus, might induce indirect physical mental health by acting microbiome-disrupting chemicals. Findings raise important question whether should consume probiotic supplement mitigate pernicious EDCs, especially BPA, offspring. Current studies investigating maternal supplementation women's offspring will be reviewed. Data inform potential application reverse unwittingly exposed these compounds striving give best start life.

Язык: Английский

Процитировано

0

Gut microbiota biodiversity indices as markers of hyperandrogenemia in women of reproductive age DOI Creative Commons
I. A. Igumnov, N. L. Belkova, A. V. Atalyan

и другие.

Acta Biomedica Scientifica (East Siberian Biomedical Journal), Год журнала: 2024, Номер 9(4), С. 12 - 18

Опубликована: Сен. 25, 2024

Introduction. Pr eviously , it was shown that the “classic” phenotypes of polycystic ovarian syndrome (PCOS) are associated with significant decrease in gut microbiota alpha diversity as compared healthy women. The aim study. T o establish cut-off points for indices, hyperandrogenism. Material and methods. he manuscript pr esents a sub-study Eastern Siberia PCOS Epidemiology Phenotype Study, conducted (Russia) from 2016 to 2019. All participants (175 women reproductive age: 26 (according Rotterdam criteria (2003)) hyperandrogenemia (increased levels total testosterone (TT) and/or free androgenindex(FAI), and/ordehydroepiandrosterone sulphate (DHEAS)), 149 – without hyperandrogenemia) were recruited during annual employment medical assessment. Methods included questionnaire survey, anthropometry modified Ferriman Gallwey score, gynecological examination, pelvic ultrasound, blood serum tests TT, DHEAS, sex hormone-binding globulin, FAI, prolactin, thyroid-stimulating hormone, 17-hydroxyprogesterone. Five indices (amplicon sequencing variant, Shannon index, Simpson Chao abundance-based coverage Index) estimated using amplicon metasequencing. Statistical analysis ROC-analysis development hyperandrogenism age PCOS. Results . According t results ROC-analysis, greatest sensitivity moderate specificity, high area under curve established classifying or 5.84 0.97, respectively. Conclusions. developed assessing most can be useful monitoring different therapeutic interventions (prebiotics, probiotics, etc.) hyperandrogenic

Язык: Английский

Процитировано

0

Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data DOI Creative Commons
Yanan Yang,

Jiale Cheng,

Chongyuan Liu

и другие.

EClinicalMedicine, Год журнала: 2024, Номер 77, С. 102884 - 102884

Опубликована: Окт. 18, 2024

Язык: Английский

Процитировано

0

Association of SOGPI in mediating the effect of Phosphatidylcholine on polycystic Ovary Syndrome DOI Creative Commons
Qian Guo, Wei Wang, Jie Chen

и другие.

Gynecological Endocrinology, Год журнала: 2024, Номер 40(1)

Опубликована: Окт. 26, 2024

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in women of reproductive age, marked by hormonal imbalances and disruptions glucose lipid metabolism. Emerging research has indicated correlation between lipids PCOS, yet the specific profiles or associated genes identified various studies vary, observational data alone cannot establish causation. Therefore, our study seeks to causal association lipidome PCOS.

Язык: Английский

Процитировано

0